Nathan L Brenner Dmd Pa Dba Franklin Family Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 443 Harrison Avenue, Franklin, NC 28734 Phone: 828-524-2162 Fax: 828-524-8468 |
Joshua D. Belof, Dmd Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1298 E Main St, Franklin, NC 28734 Phone: 828-634-7900 |
Gerald L. Maize, D.d.s., P.a. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 581 W Palmer St, Franklin, NC 28734 Phone: 828-524-2222 Fax: 828-524-5416 |
James W. Davis, Dds,ms,pa Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 59 Georgia Rd, Franklin, NC 28734 Phone: 828-524-2244 |
Appalachian Dental Associates Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 329 Westgate Plz, Franklin, NC 28734 Phone: 828-369-0618 Fax: 828-349-4913 |
James F. Melzer, Jr.; Dmd, Pa Dentist Medicare: Not Enrolled in Medicare Practice Location: 329 Westgate Plaza, Franklin, NC 28734 Phone: 828-369-0618 Fax: 828-349-4913 |
Joshua Cardinal Dds, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 499 Dowdle Mountain Rd, Franklin, NC 28734 Phone: 828-332-3097 |
David E Henson Dds Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 316 W Main Street, Franklin, NC 28734 Phone: 828-524-2163 Fax: 828-369-2753 |
Matthew G Corbin, Dds, Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 624 W Palmer St, Franklin, NC 28734 Phone: 828-524-6111 |
News Archive
Dr Shelby Temple, from the University of Bristol's School of Biological Sciences, has been named Innovator of the Year 2017 for his ground-breaking work into polarization and macular degeneration.
Merck & Co., Inc. today announced that, as of the close of business on August 13, 2010, the outstanding shares of the company's 6.00% Mandatory Convertible Preferred Stock will mandatorily convert by their terms into a right to receive cash and shares of Merck common stock.
Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.
Similar to the dozens of Sherpas that guide hikers up treacherous Himalayan mountains to reach a summit, the nervous system relies on elaborate timing and location of guidance cues for neuronal axons-threadlike projections-to successfully reach their destinations in the body.
› Verified 2 days ago